Literature DB >> 31036368

Omega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling.

Meredith A Baker1, Prathima Nandivada1, Paul D Mitchell2, Gillian L Fell1, Amy Pan1, Bennet S Cho1, Denis J De La Flor1, Lorenzo Anez-Bustillos1, Duy T Dao1, Vania Nosé3, Mark Puder4.   

Abstract

BACKGROUND: A single dose of IV fish oil (FO) before hepatic ischemia reperfusion injury (HIRI) increases hepatocyte proliferation and reduces necrosis in wild type (WT) mice. It has been suggested that the GPR120 receptor on Kupffer cells mediates FO's ability to reduce HIRI. The purpose of this study was to determine whether GPR120 is required for FO to reduce HIRI.
METHODS: Sixty-four (n = 8/group) adult male WT (C57BL/6) and GPR120 knockout (KO) mice received IV FO (1 g/kg) or saline 1 h prior to HIRI or sham operation. Mice were euthanized 24 h postoperatively for analysis of hepatic histology, NFκB activity, and serum alanine transaminase (ALT) levels.
RESULTS: FO pretreated livers had less necrosis after HIRI than saline pretreated livers in both WT (mean ± SEM 25.9 ± 7.3% less, P = 0.007) and KO (36.6 ± 7.3% less, P < 0.0001) mice. There was no significant difference in percent necrosis between WT-FO and KO-FO groups. Sham groups demonstrated minimal necrosis (0-1.9%). Mean [95% CI] ALT after HIRI was significantly higher (P = 0.04) in WT-Saline mice (1604 U/L [751-3427]) compared to WT-FO (321 U/L [150-686]) but was not significantly higher in KO-Saline mice compared to KO-FO. There were no differences in ALT between WT-FO and KO-FO mice who underwent HIRI or between groups who underwent sham surgery. There were no differences in NFκB or IKKβ activation among groups as measured by Western blot analysis.
CONCLUSIONS: IV FO pretreatment was able to reduce HIRI in GPR120 KO mice, suggesting the hepatoprotective effects of FO are not mediated by GPR120 alone.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fish oil; Free fatty acid receptor 4; GPR120; Ischemia; Liver; Reperfusion

Mesh:

Substances:

Year:  2019        PMID: 31036368      PMCID: PMC6790164          DOI: 10.1016/j.jpedsurg.2019.04.003

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  35 in total

Review 1.  Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection.

Authors:  V E de Meijer; B T Kalish; M Puder; J N M Ijzermans
Journal:  Br J Surg       Date:  2010-09       Impact factor: 6.939

2.  Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol.

Authors:  K Soltys; G Dikdan; B Koneru
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 3.  Current clinical applications of omega-6 and omega-3 fatty acids.

Authors:  Sang Lee; Kathleen M Gura; Sendia Kim; Danielle A Arsenault; Bruce R Bistrian; Mark Puder
Journal:  Nutr Clin Pract       Date:  2006-08       Impact factor: 3.080

Review 4.  Resolvins and protectins in inflammation resolution.

Authors:  Charles N Serhan; Nicos A Petasis
Journal:  Chem Rev       Date:  2011-07-18       Impact factor: 60.622

5.  Safety of donors in live donor liver transplantation using right lobe grafts.

Authors:  S T Fan; C M Lo; C L Liu; B H Yong; J K Chan; I O Ng
Journal:  Arch Surg       Date:  2000-03

6.  Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy.

Authors:  Michael Linecker; Perparim Limani; Patryk Kambakamba; Philipp Kron; Christoph Tschuor; Nicolas Calo; Michelangelo Foti; Jean-François Dufour; Rolf Graf; Bostjan Humar; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2017-08       Impact factor: 12.969

Review 7.  Nuclear factor-kappaB: its role in health and disease.

Authors:  Ashok Kumar; Yasunari Takada; Aladin M Boriek; Bharat B Aggarwal
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

8.  Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center.

Authors:  M E de Vera; R Lopez-Solis; I Dvorchik; S Campos; W Morris; A J Demetris; P Fontes; J W Marsh
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

Review 9.  Inflammation and lipid signaling in the etiology of insulin resistance.

Authors:  Christopher K Glass; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

10.  N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury.

Authors:  Jessica Zúñiga; Milena Cancino; Fernando Medina; Patricia Varela; Romina Vargas; Gladys Tapia; Luis A Videla; Virginia Fernández
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

View more
  4 in total

1.  Feasibility and safety of magnetic-end double-J ureteral stent insertion and removal in children.

Authors:  Marc Chalhoub; Jules Kohaut; Nicolas Vinit; Nathalie Botto; Yves Aigrain; Yves Héloury; Henri Lottmann; Thomas Blanc
Journal:  World J Urol       Date:  2020-07-04       Impact factor: 4.226

2.  Synthesis of encapsulated fish oil using whey protein isolate to prevent the oxidative damage and cytotoxicity of titanium dioxide nanoparticles in rats.

Authors:  Mosaad A Abdel-Wahhab; Aziza A El-Nekeety; Hagar E Mohammed; Tamer M El-Messery; Mohamed H Roby; Sekena H Abdel-Aziem; Nabila S Hassan
Journal:  Heliyon       Date:  2021-11-24

3.  Changes in the Serum Fatty Acid Profile After Anhepatic Phase of Orthotopic Liver Transplantation Procedure.

Authors:  Aleksandra Hliwa; Adriana Mika; Maciej Sledzinski; Dariusz Laski; Bruno Ramos-Molina; Tomasz Sledzinski
Journal:  Front Physiol       Date:  2022-03-29       Impact factor: 4.566

4.  ω-3 fatty acid-enriched parenteral nutrition shortens hospital stay in acute variceal bleeding cirrhotic patients.

Authors:  Seong-Jung Kim; In Ae Chun; Ju-Yeon Cho; Jun Hyung Lee; Jun Lee; Young-Dae Kim; Chan-Guk Park
Journal:  Medicine (Baltimore)       Date:  2022-04-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.